Should I buy or sell Genus stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GNS shares. View GNS analyst ratings or view top-rated stocks .

What is Genus' stock price target for 2024?

1 Wall Street research analysts have issued 12 month price objectives for Genus' shares. Their GNS share price targets range from GBX 4,500 to GBX 4,500. On average, they expect the company's share price to reach GBX 4,500 in the next year. This suggests a possible upside of 156.3% from the stock's current price. View analysts price targets for GNS or view top-rated stocks among Wall Street analysts .

How have GNS shares performed in 2024?

Genus' stock was trading at GBX 2,170 at the start of the year. Since then, GNS shares have decreased by 19.1% and is now trading at GBX 1,756. View the best growth stocks for 2024 here .

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus announced a dividend on Thursday, February 22nd. Investors of record on Thursday, February 29th will be paid a dividend of GBX 10.30 per share on Thursday, March 28th. This represents a yield of 0.54%. The ex-dividend date is Thursday, February 29th. The official announcement can be viewed at this link . Read our dividend analysis for GNS .

Is Genus a good dividend stock?

Genus (LON:GNS) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 1.80%. The dividend payout ratio is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for GNS .

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN) , Glencore (GLEN) , Tesco (TSCO) , AstraZeneca (AZN) , British American Tobacco (BATS) , Cronos Group (CRON) , Dairy Crest Group (DCG) , Debenhams (DEB) , Diageo (DGE) and Experian (EXPN) .

How do I buy shares of Genus?

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:GNS

Genus (GNS) Share Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free GNS Stock Alerts

GBX 1,756

+4.00 (+0.23%)

(As of 04/18/2024 ET)

Compare

Today's Range: 1,740
▼
1,798
50-Day Range: 1,637
▼
2,200
52-Week Range: 1,478
▼
2,798

Volume: 186,329 shs
Average Volume: 92,921 shs
Market Capitalization: £1.16 billion

P/E Ratio: 3,443.14
Dividend Yield: 1.82%
Price Target: GBX 4,500

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines Insider Trades

Get Genus alerts:

Genus MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 156.3% Upside
GBX 4,500 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.00 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Genus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Genus has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for GNS.

0.8

Dividend Strength

Dividend Yield
Genus pays a meaningful dividend of 1.80%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Genus does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Genus is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for GNS.

0.6

News and Social Media Coverage

Search Interest
21 people have searched for GNS on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Genus insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.69% of the stock of Genus is held by insiders.
Percentage Held by Institutions
78.24% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Genus is 3,443.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 144.13.
Price to Earnings Ratio vs. Sector
The P/E ratio of Genus is 3,443.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 254.51.
Price to Earnings Growth Ratio
Genus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Genus has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Genus Stock (LON:GNS)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GNS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GNS Stock News Headlines

April 2, 2024 | msn.com

Fact Check: Video Claimed Scuba Diver Swam With Dinosaur. Here's the Truth

March 14, 2024 | msn.com

Should I buy the current dogs of the FTSE 250?

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 25, 2024 | finance.yahoo.com

Genus plc (LON:GNS) Just Reported Earnings, And Analysts Cut Their Target Price

February 22, 2024 | lse.co.uk

Genus touts programme to boost investment returns as profit declines

February 22, 2024 | finance.yahoo.com

Genus plc Reports Interim Results for the Six Months Ended 31 December 2023

February 16, 2024 | finance.yahoo.com

Estimating The Intrinsic Value Of Genus plc (LON:GNS)

February 15, 2024 | lse.co.uk

London midday: Stocks dip as investors mull GDP; airlines fly higher

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 14, 2024 | wsj.com

Genus PLC

December 31, 2023 | finance.yahoo.com

Shareholders in Genus (LON:GNS) are in the red if they invested three years ago

November 25, 2023 | morningstar.com

Genus PLC GNS

November 13, 2023 | finance.yahoo.com

Institutional owners may take dramatic actions as Genus plc's (LON:GNS) recent 5.0% drop adds to one-year losses

November 4, 2023 | uk.investing.com

London midday: Stocks nudge lower; all eyes on payrolls report

September 7, 2023 | msn.com

Why You Should Grow Native Plants in Your Garden

September 7, 2023 | finance.yahoo.com

Genus plc Preliminary Results for the Year Ended 30 June 2023

September 5, 2023 | benzinga.com

Thinking about buying stock in Scilex Holding, iCoreConnect, Genius Group, Helius Medical Technologies, or TradeUP Acquisition?

August 10, 2023 | finance.yahoo.com

A Look At The Fair Value Of Genus plc (LON:GNS)

July 23, 2023 | finance.yahoo.com

Genus' (LON:GNS) earnings trajectory could turn positive as the stock climbs 4.9% this past week

May 18, 2023 | msn.com

Peel Hunt Limited Reiterates Genus (LSE:GNS) Buy Recommendation

May 16, 2023 | uk.investing.com

FTSE 100 falls to fresh lows as wall Street makes weak start

May 15, 2023 | finance.yahoo.com

Should Weakness in Genus plc's (LON:GNS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

April 27, 2023 | finance.yahoo.com

Genus plc (GNS.L)

April 22, 2023 | benzinga.com

Genius Gr Stock (AMEX:GNS), Short Interest Report

February 23, 2023 | finance.yahoo.com

Genus plc Interim results for the six months ended 31 December 2022

February 13, 2023 | finance.yahoo.com

Genus' (LON:GNS) investors will be pleased with their favorable 31% return over the last five years

December 26, 2022 | finance.yahoo.com

With 80% ownership, Genus plc (LON:GNS) boasts of strong institutional backing

See More Headlines

Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/28 Dividend: 2/29/2024
Dividend Payable: 3/28/2024
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:GNS
CUSIP: N/A
CIK: N/A
Web: www.genusplc.com
Phone: +44-1256-347100
Fax: N/A
Employees: 3,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 4,500
High Stock Price Target: GBX 4,500
Low Stock Price Target: GBX 4,500
Potential Upside/Downside: +155.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX 0.51
Trailing P/E Ratio: 3,448.63
Forward P/E Ratio: 19.64
P/E Growth: 2.87
Net Income: £33.40 million
Net Margins: 4.96%
Pretax Margin: N/A
Return on Equity: 5.27%
Return on Assets: 3.18%

Debt

Debt-to-Equity Ratio: 50.99
Current Ratio: 2.15
Quick Ratio: 1.08

Sales & Book Value

Annual Sales: £673.10 million
Price / Sales: 1.73
Cash Flow: GBX 34.78 per share
Price / Cash Flow: 50.56
Book Value: GBX 875 per share
Price / Book: 2.01

Miscellaneous

Outstanding Shares: 66,030,000
Free Float: N/A
Market Cap: £1.16 billion
Optionable: Not Optionable
Beta: 0.31

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Jorgen Kokke (Age 56)
Chief Executive Officer & Director
Comp: $578.89k
Ms. Alison Jane Henriksen ACA (Age 57)
CFO & Executive Director
Comp: $605k
Dr. Matt Culbertson
Chief Operating Officer
Dr. Elena Rice
Head of R&D and Chief Scientific Officer
Mr. Daniel William David Hartley
Group General Counsel & Company Secretary
Ms. Angelle R. Rosata
Group Human Resources Director
Mr. Jerry Thompson
Chief Operating Officer of Genus ABS Beef
Andrew Thompson
Head of ABS EMEA
Ms. Janet Duane
Group Financial Controller

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

GNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Genus stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GNS shares.
View GNS analyst ratings or view top-rated stocks.
What is Genus' stock price target for 2024?: 1 Wall Street research analysts have issued 12 month price objectives for Genus' shares. Their GNS share price targets range from GBX 4,500 to GBX 4,500. On average, they expect the company's share price to reach GBX 4,500 in the next year. This suggests a possible upside of 156.3% from the stock's current price.
View analysts price targets for GNS or view top-rated stocks among Wall Street analysts.
How have GNS shares performed in 2024?: Genus' stock was trading at GBX 2,170 at the start of the year. Since then, GNS shares have decreased by 19.1% and is now trading at GBX 1,756.
View the best growth stocks for 2024 here.
How often does Genus pay dividends? What is the dividend yield for Genus?: Genus announced a dividend on Thursday, February 22nd. Investors of record on Thursday, February 29th will be paid a dividend of GBX 10.30 per share on Thursday, March 28th. This represents a yield of 0.54%. The ex-dividend date is Thursday, February 29th. The official announcement can be viewed at this link.
Read our dividend analysis for GNS.

Is Genus a good dividend stock?: Genus (LON:GNS) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 1.80%. The dividend payout ratio is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GNS.
What other stocks do shareholders of Genus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN).
How do I buy shares of Genus?: Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:GNS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Genus (GNS) Share Price, News & Analysis

Genus MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About Genus Stock (LON:GNS)

GNS Stock Price History

GNS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

GNS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™